Holen Sie sich die Stockscreener-App
580.37
0.82%
-4.78
Vorhandelsmarkt:
576.03
-4.34
-0.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$585.15
Offen:
$581.94
24-Stunden-Volumen:
1.92M
Relative Volume:
0.95
Marktkapitalisierung:
$218.05B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
33.53
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
-2.91%
1M Leistung:
+2.29%
6M Leistung:
+46.38%
1J Leistung:
+9.51%
1-Tages-Spanne:
$577.96
$584.45
1-Wochen-Bereich:
$577.96
$597.68
52-Wochen-Spanne:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
580.37 | 219.85B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.59 | 158.32B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
732.73 | 58.21B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.81 | 42.49B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.63 | 38.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Transmission Immersion Probe Market Size to Hit USD 2.58 Billion by 2033 | SNS Insider - GlobeNewswire Inc.
New Bioprocess Design Center In Hyderabad Boosts Thermo Fisher’s Asian Bioprocessing Capabilities - Sahyadri Startups
India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher expands bioprocessing capabilities across Asia By Investing.com - Investing.com India
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $670 From $656, Keeps Overweight Rating - MarketScreener
As the bio industry grows, Thermo Fisher Scientific (TMO), the world's No. 1 producer of life scienc.. - 매일경제
Thermo Fisher Scientific issues €2.1 billion in euro-denominated senior notes - Investing.com Nigeria
Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes - MSN
HSBC Upgrades Thermo Fisher Scientific (TMO) - Nasdaq
Morgan Stanley assumes coverage on Thermo Fisher stock with Overweight rating - Investing.com
Thermo Fisher Issues €2.1 Billion in Senior Notes - TipRanks
Thermo Fisher Scientific (NYSE: TMO) prices €2.09B in 2027 and 2035 notes - Stock Titan
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts - ts2.tech
VP Lowery Files To Sell 6,913 Of Thermo Fisher Scientific Inc [TMO] - TradingView
Thermo Fisher (NYSE: TMO) insider plans Rule 144 sale of 6,913 common shares - Stock Titan
Pittsburgh Playhouse, Thermo Fisher Scientific, East End Food Co-op and more: Pittsburgh jobs for 12/1/25 - NEXTpittsburgh
Thermo Fisher Scientific launches CorEvitas Clinical Registry for rare autoimmune disorder - scientistlive.com
FDA approves lung cancer diagnostic test - scientistlive.com
HSBC Upgrades Thermo Fisher Scientific to Buy From Hold, Adjusts Price Target to $670 From $550 - MarketScreener
Is Thermo Fisher Scientific Inc TN8 a good long term investmentBull Market Opportunities & Double Digit Profit Strategies - earlytimes.in
10 Best Dividend Stocks Hedge Funds Are Buying - Insider Monkey
A Look At The Intrinsic Value Of Thermo Fisher Scientific Inc. (NYSE:TMO) - Yahoo Finance
Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025 - ts2.tech
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? - MSN
14-year-old won $25,000 and 1st place for his innovative work on origami - Business Insider
Thermo Fisher Scientific Insider Sold Shares Worth $6,435,000, According to a Recent SEC Filing - MarketScreener
North America Mass Spectrometry Market Report 2025-2033, - GlobeNewswire
Aug Closing: Is Thermo Fisher Scientific Inc. stock a good choice for value investorsPortfolio Performance Summary & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
Is the Market Bullish or Bearish on Thermo Fisher Scientific Inc? - Benzinga
Laboratory Informatics Market- By Type Thermo Fisher - openPR.com
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN
Thermo Fisher executive Shafer sells $6.43 million in stock By Investing.com - Investing.com India
TMO insider Michael D. Shafer reports major option exercise and stock sale - Stock Titan
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad - GlobeNewswire
Thermo Fisher launches bioprocess design centre in Hyd - The Hans India
TMO insider files Form 144 for 10,725-share NYSE sale - Stock Titan
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today - Sahm
Thermo Fisher Inaugurates Customer Experience and Bioprocess Centre’s in Hyderabad - Chemical Industry Digest
Medical Precision Parts Market Research Report 2025-2030 Featuring Key PlayersGemsons, ARC, Precision Resource, Thermo Fisher Scientific, Stryker, Linamar, and TS PrototypesResearchAndMarkets.com - Business Wire
Thermo Fisher Scientific prices offering of senior notes - Medical Buyer
Competent Cells Market to Get an Explosive Growth| Thermo Fisher - openPR.com
Gene Silencing Market Is Booming Worldwide 2025-2032 | Thermo - openPR.com
Cell Culture Media Market Growing Trends and Demands Analysis - openPR.com
Thermo Fisher expands India footprint with Customer Experience, Bioprocess Design Centers at Genome... - Medical Dialogues
Thermo Fisher Scientific Prices Offering of Euro-Denominated Notes at 100% of Par Value - MarketScreener
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - BioSpace
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):